Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Reckitt Benckiser (OP: RBGPF )

59.24 -0.45 (-0.76%)
Streaming Delayed Price Updated: 3:37 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,685
Open 59.70
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 59.69
Today's Range 59.24 - 62.48
52wk Range 50.76 - 75.72
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
FDA proposes removing oral phenylephrine from OTC drugs for nasal congestion, citing ineffectiveness. Public comments open before a final order is issued. 
Via Benzinga
Exposures Product Safety
Consumer Giant Reckitt Seeks Help From Investment Banks To Evaluate Options For Homecare Brands, Baby Formula
Reckitt Benckiser is reportedly in early talks to sell its homecare division, featuring brands like Air Wick and Calgon, as part of a broader strategy to focus on consumer health and hygiene. The sale... 
Via Benzinga

Performance

YTD
-14.13%
-14.13%
1 Month
-5.93%
-5.93%
3 Month
+3.03%
+3.03%
6 Month
+7.07%
+7.07%
1 Year
-14.03%
-14.03%

More News

Read More
Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
What's Going On With Abbott Laboratories Stock On Friday?
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Durex Owner Reckitt Benckiser Taps Into China's Livestreaming Trend To Sell Condoms Online
Via Benzinga
British Consumer Company Reckitt Benckiser's CEO Steps Down
Via Benzinga
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
Via Benzinga
Exposures Product Safety
Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process
Via Benzinga
Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report
Via Benzinga
Baby Formula Startup Seeks To Compete Abbott With 15% Market Share: Report
Via Benzinga
Is Church & Dwight Co. Inc. (NYSE: CHD) a Buy for Dividend Investors?
Via MarketBeat
Reckitt Lifts Annual Forecast On Higher Prices, Baby Formula Shortage
Via Benzinga
More Companies Join Race To Ease US Baby Formula Supply Crunch
Via Benzinga
Danone Scales Up Baby Formula Shipments To US To Combat Shortage: Reuters
Via Benzinga
Morning Brief: Top Financial Stories Dominating on Friday, April 29
Via Benzinga
Reckitt Benckiser Hikes Prices To Compensate For Falling Demand: FT
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.